Genetic diagnosis of intimate diseases

Material: swab
Price of the study: 300 PLN
Waiting time: result after 20 working days

  • Advance appointment booking required.

Go to eReservation Go to store

Preparation for the study

Detailed for women

  • The test should not be performed:
    - during menstruation,
    - during treatment with antibiotics,
    - during treatment with vaginal preparations (globules, creams),
    - when irrigations are used,
    - within 48 hours after the last sexual intercourse.
    On the day of the test, the genital area should be washed without using soap or intimate hygiene gels.
    If treatment has been used, a 3-5 day break is recommended between the end of treatment
    and the performance of the test.
  • The material for the test is a swab from the cervix, vagina, urethral outlet.

Detailed for men

  • The material for the test is a swab from the mouth of the urethra, the gastric groove.
  • Preparation for the test:
    - 48 h before the test refrain from sexual intercourse
    - 48 h before the examination do not use antibiotics, medicinal creams
    - 48 h before the examination limit genital hygienic procedures
    - on the day of the examination wash the genital area without using soap and intimate hygiene gels


Samples brought from outside are not accepted for testing.
It is necessary to attach a document-"Referral and consent for LUXMED genetic testing. Available in the Patient's Essentials - Downloadable forms


Genetic testing for sexually transmitted diseases ( STIs).
STIs (sexually transmitted infections) due to the mode of infection, risk factors and symptoms are often confused with each other. The course of treatment differs for some of them, so it is important to identify the infectious agent. For this reason, the most convenient and economical option for laboratory testing is to determine as many STI-type pathogens as possible in one package.

The test uses a PCR test that detects the presence of 9 pathogens that cause sexually transmitted infections in a single assay: Chlamydia trachomatis, Neisseria gonorrhoeae, Gardnerella vaginalis, HSV-1, HSV-2 ( herpes virus), Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum.

The most common genitourinary diseases are chlamydiosis, mycoplasmosis, gonorrhea and cysticercosis. Ureaplasma infection, herpes zoster, is also relatively common. The most important risk factors that favor urogenital infections include:
- large number and/or frequent changes of sexual partners
- use of oral contraceptives
- antibiotic therapy
- immunocompromised states
- certain diseases, e.g. diabetes, cancer
- pregnancy (increased susceptibility)
Untreated infections lead to serious complications such as pelvic inflammatory conditions, urethritis, premature birth, malformations in the unborn child (low birth weight, neurological disorders, blindness) and infertility.

Some infections may be asymptomatic and lead to infection of the sexual partner. The test is also applicable after previous treatment to confirm its effectiveness.

Advantages of the test:
- Reliable identification of mixed infections, even asymptomatic or sparse infections
- Analysis of non-culturable pathogens (T. pallidum)
- Rapid evaluation of difficult-to-culture pathogens (Chlamydia, Mycoplasma, Ureaplasma)
- Diagnosis of the early phase of infection, undetectable by serological tests
- Excellent tool for screening STI pathogens (e.g., in risk groups. in at-risk groups)
- Use in prevention and diagnosis of infertility and miscarriage
- Preventive testing in immunosuppressed patients (e.g. HIV+)

Development and preparation of material (applies to contractors only)

Enter a one-time code:Show